TY - JOUR
T1 - Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia
AU - Bizzarri, C.
AU - Ubertini, G.
AU - Crea, F.
AU - Colabianchi, D.
AU - Loche, S.
AU - Ravà, L.
AU - Cappa, M.
PY - 2009/12
Y1 - 2009/12
N2 - Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95% confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95% CI: 0.06-0.35 - ß=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.
AB - Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95% confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95% CI: 0.06-0.35 - ß=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.
KW - Child
KW - Congenital adrenal hyperplasia
KW - Exercise
KW - GH
KW - Growth
UR - http://www.scopus.com/inward/record.url?scp=77649208902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77649208902&partnerID=8YFLogxK
U2 - 10.3275/6381
DO - 10.3275/6381
M3 - Article
C2 - 19564720
AN - SCOPUS:77649208902
VL - 32
SP - 903
EP - 907
JO - Journal of Endocrinological Investigation
JF - Journal of Endocrinological Investigation
SN - 0391-4097
IS - 11
ER -